191 related articles for article (PubMed ID: 15748890)
1. The actin cytoskeleton-associated protein zyxin acts as a tumor suppressor in Ewing tumor cells.
Amsellem V; Kryszke MH; Hervy M; Subra F; Athman R; Leh H; Brachet-Ducos C; Auclair C
Exp Cell Res; 2005 Apr; 304(2):443-56. PubMed ID: 15748890
[TBL] [Abstract][Full Text] [Related]
2. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL
Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038
[TBL] [Abstract][Full Text] [Related]
3. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
[TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth.
Carrillo J; García-Aragoncillo E; Azorín D; Agra N; Sastre A; González-Mediero I; García-Miguel P; Pestaña A; Gallego S; Segura D; Alonso J
Clin Cancer Res; 2007 Apr; 13(8):2429-40. PubMed ID: 17438102
[TBL] [Abstract][Full Text] [Related]
5. EWS-FLI1 causes neuroepithelial defects and abrogates emigration of neural crest stem cells.
Coles EG; Lawlor ER; Bronner-Fraser M
Stem Cells; 2008 Sep; 26(9):2237-44. PubMed ID: 18556509
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of CD99-induced caspase-independent cell death and cell-cell adhesion in Ewing's sarcoma cells: actin and zyxin as key intracellular mediators.
Cerisano V; Aalto Y; Perdichizzi S; Bernard G; Manara MC; Benini S; Cenacchi G; Preda P; Lattanzi G; Nagy B; Knuutila S; Colombo MP; Bernard A; Picci P; Scotlandi K
Oncogene; 2004 Jul; 23(33):5664-74. PubMed ID: 15184883
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cell features of Ewing tumors.
Tirode F; Laud-Duval K; Prieur A; Delorme B; Charbord P; Delattre O
Cancer Cell; 2007 May; 11(5):421-9. PubMed ID: 17482132
[TBL] [Abstract][Full Text] [Related]
8. EWS/FLI1 regulates tumor angiogenesis in Ewing's sarcoma via suppression of thrombospondins.
Potikyan G; Savene RO; Gaulden JM; France KA; Zhou Z; Kleinerman ES; Lessnick SL; Denny CT
Cancer Res; 2007 Jul; 67(14):6675-84. PubMed ID: 17638877
[TBL] [Abstract][Full Text] [Related]
9. Response of Ewing tumor cells to forced and activated p53 expression.
Kovar H; Pospisilova S; Jug G; Printz D; Gadner H
Oncogene; 2003 May; 22(21):3193-204. PubMed ID: 12761489
[TBL] [Abstract][Full Text] [Related]
10. Context matters: the hen or egg problem in Ewing's sarcoma.
Kovar H
Semin Cancer Biol; 2005 Jun; 15(3):189-96. PubMed ID: 15826833
[TBL] [Abstract][Full Text] [Related]
11. The conformational state of Tes regulates its zyxin-dependent recruitment to focal adhesions.
Garvalov BK; Higgins TE; Sutherland JD; Zettl M; Scaplehorn N; Köcher T; Piddini E; Griffiths G; Way M
J Cell Biol; 2003 Apr; 161(1):33-9. PubMed ID: 12695497
[TBL] [Abstract][Full Text] [Related]
12. RNAi knockdown of the focal adhesion protein TES reveals its role in actin stress fibre organisation.
Griffith E; Coutts AS; Black DM
Cell Motil Cytoskeleton; 2005 Mar; 60(3):140-52. PubMed ID: 15662727
[TBL] [Abstract][Full Text] [Related]
13. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
[TBL] [Abstract][Full Text] [Related]
14. Detection and molecular cytogenetic characterization of a novel ring chromosome in a histological variant of Ewing sarcoma.
Szuhai K; IJszenga M; Tanke HJ; Taminiau AH; de Schepper A; van Duinen SG; Rosenberg C; Hogendoorn PC
Cancer Genet Cytogenet; 2007 Jan; 172(1):12-22. PubMed ID: 17175374
[TBL] [Abstract][Full Text] [Related]
15. Expression and regulation of the transcriptional repressor ZNF43 in Ewing sarcoma cells.
González-Lamuño D; Loukili N; García-Fuentes M; Thomson TM
Pediatr Pathol Mol Med; 2002; 21(6):531-40. PubMed ID: 12537770
[TBL] [Abstract][Full Text] [Related]
16. The oncogenic fusion protein EWS/NOR-1 induces transformation of CFK2 chondrogenic cells.
Filion C; Labelle Y
Exp Cell Res; 2004 Jul; 297(2):585-92. PubMed ID: 15212958
[TBL] [Abstract][Full Text] [Related]
17. Mechanical forces facilitate actin polymerization at focal adhesions in a zyxin-dependent manner.
Hirata H; Tatsumi H; Sokabe M
J Cell Sci; 2008 Sep; 121(Pt 17):2795-804. PubMed ID: 18682496
[TBL] [Abstract][Full Text] [Related]
18. Cleavage of the Ewing tumour-specific EWSR1-FLI1 mRNA by hammerhead ribozymes.
Hühn R; Staege MS; Hesse M; Liebig B; Burdach SE
Anticancer Res; 2009 Jun; 29(6):1901-8. PubMed ID: 19528446
[TBL] [Abstract][Full Text] [Related]
19. Decreased wild-type full-length Et-A and -B receptors in neuroblastoma and Ewing sarcoma cells.
Berry PA; Zhang YF; Carter ND; Jeffery S; Burchill SA
Med Pediatr Oncol; 2001 Jan; 36(1):142-6. PubMed ID: 11464869
[TBL] [Abstract][Full Text] [Related]
20. RNA-based nanoparticle treatment shows promise in Ewing's sarcoma model.
Hede K
J Natl Cancer Inst; 2005 May; 97(9):627. PubMed ID: 15870430
[No Abstract] [Full Text] [Related]
[Next] [New Search]
